SYMPOSIUM PRESENTERS

Nicole Baumer, MD, MEd, Director, Boston Children's Hospital Down Syndrome Program

Brian Beldon, PhD, Child Psychologist; Clinical Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine

Peter Bulova, MD, Associate Professor of Medicine; Co-Director, Magee Center for Women with Disabilities; Director, University of Pittsburgh Adult Down Syndrome Center

W. Scott Butsch, MD, MSc, FTOS, Director of Obesity Medicine, Bariatric and Metabolic Institute, Cleveland Clinic

George Capone, MD, Director, Kennedy Krieger Institute's Down Syndrome Clinic and Research Center

Brian Chicoine, MD, Medical Director, Advocate Medical Group Adult Down Syndrome Center

Bryn Gelaro, LSW, Director of Adult Initiatives and Special Projects, Global Down Syndrome Foundation

Natalie Haultain, PsyD, Clinical Psychologist; Clinical Assistant Professor of Pediatrics, University of Missouri-Kansas City School of Medicine

Jordan Jones, MD, Rheumatology Division, Children's Mercy Kansas City; Assistant Professor of Pediatrics,University of Missouri-Kansas City School of Medicine

Corey Keeton, MD, Assistant Professor of Psychiatry, University of Cincinnati

Nicolas Oreskovic, MD, MPH, Internal Medicine and Pediatrics, Massachusetts General Hospital; Assistant Professor of Pediatrics, Harvard Medical School

Naira Pereyra-Muñoz, MD, Pediatric Ophthalmologist, Star Médica Private Children's Hospital, Mexico City, Mexico

Brian Skotko, MD, Director, Down Syndrome Program at Massachusetts General Hospital; Associate Professor, Harvard Medical School

Noemi Spinazzi, MD, Medical Director, Down Syndrome Clinic at UCSF Benoiff Children's Hospital Oakland; Assistant Clinical Professor, UCSF School of Medicine

Kishore Vellody, MD, President, National Down Syndrome Congress; Medical Director, Down Syndrome Center of Western Pennsylvania; Professor of Pediatrics, University of Pittsburgh School of Medicine

Luke Wall, MD, Associate Clinical Professor, Pediatrics, Section of Allergy Immunology, LSU and Children's Hospital

Lauren Wang, MD, Assistant Professor, Department of Family and Community Medicine, University of Cincinnati

Michelle Whitten, Co-Founder, President and CEO of Global Down Syndrome Foundation

SYMPOSIUM PLANNING COMMITTEE

Nicole Baumer, MD, MEd, Director, Boston Children's Hospital Down Syndrome Program

Gabriela Eguiarte, MD, Pediatrician, Angeles Pedregal Hospital, Mexico

Katie Frank, PhD, OTR/L, Occupational Therapist III, Advocate Medical Group Adult Down Syndrome Center

Judy Kim, MD, Assistant Professor, Center for Transition Medicine, Baylor College of Medicine

Andrew McCormick, MD, Director, Healthy Transitions Program, Down Syndrome Center of Western Pennsylvania; Associate Professor of Pediatrics, University of Pittsburgh School of Medicine

Lina Patel, PsyD, Director of Psychology, Anna and John J. Sie Center for Down Syndrome at Children's Hospital Colorado

Emilie Perkins, Director of Client and Conference Services, Raybourn Group International

Noemi Spinazzi, MD, Medical Director, Down Syndrome Clinic at UCSF Benoiff Children's Hospital Oakland; Assistant Clinical Professor, UCSF School of Medicine

Maria Stanley, MD, FAAP, Annual Symposium Committee Co-Chair; Clinical Associate Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic

POLICY ON DISCLOSURE

It is the policy of the University of Wisconsin-Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this continuing education (CE) activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made available.

*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.